Jeisys Medical Inc.

    Jeisys Medical Inc.

    KKRX:287410
    12,900.00
    KRW
    +20.00
    (+0.16%)
    35.09P/E
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    TTM
    Revenue per Share
    - -
    - -
    - -
    875.08
    1,166.36
    1,636.78
    1,891.65
    2,200.85
    Basic EPS, GAAP
    -8
    -1.26
    9
    138
    195
    381
    328
    366.79
    Free Cash Flow per Basic Share
    -8.96
    -21.63
    12.06
    240.52
    251.32
    164.86
    233.57
    140.31
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    93.81
    134.6
    103.05
    -64.84
    200.79
    577.54
    878.74
    - -
    Tangible Book Value per Share
    1,144.22
    2,492.37
    1,750.56
    294.85
    669.78
    1,098.87
    1,247.77
    1,480.46
    Basic Weighted Avg Shares
    1
    3
    4
    55
    70
    71
    76
    76
    Sales/Revenue/Turnover
    - -
    - -
    - -
    47,829
    81,296
    116,550
    143,030
    167,823
    Operating Margin (%)
    - -
    - -
    - -
    23.06
    29.04
    29.2
    25.39
    35.41
    Depreciation Expense
    - -
    - -
    - -
    2,329
    2,474
    3,041
    4,263
    3,387
    Net Income, GAAP
    -6
    -4
    40
    7,543
    13,592
    27,130
    24,800
    27,969
    Effective Tax Rate (%)
    - -
    - -
    15.2
    12.95
    - -
    20.29
    29.27
    25.72
    Profit Margin (%)
    - -
    - -
    - -
    15.77
    16.72
    23.28
    17.34
    16.67
    Working Capital
    1,392
    8,251
    8,319
    15,346
    30,146
    47,900
    66,991
    64,250
    LT Debt
    539
    563
    587
    8,125
    1,729
    11,315
    22,271
    - -
    Total Equity
    826
    7,663
    7,703
    16,959
    47,654
    79,955
    96,250
    112,891
    Return on Invested Capital (%)
    - -
    - -
    -0.55
    50.89
    - -
    33.23
    22.86
    38.91
    Return on Capital (%)
    - -
    - -
    5.98
    167.11
    - -
    64.97
    32.6
    76.41
    Return on Common Equity (%)
    - -
    -1.6
    9.13
    - -
    - -
    98.44
    46.11
    102.61

    Capital Structure

    KRW

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    3,336
    43,238
    - -
    LT Borrowings
    21,083
    20,974
    - -
    LT Finance Leases
    1,188
    985
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    75
    75
    75
    Market Capitalization
    787,528
    606,845
    981,389

    Working Capital

    KRW

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    90,510
    142,713
    128,604
    Cash, Cash Equivalents & STI
    48,830
    96,583
    - -
    Accounts Receivable, Net
    14,042
    17,407
    - -
    Inventories
    22,617
    24,060
    - -
    Total Current Liabilities
    23,519
    67,191
    64,355
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    3,336
    43,238
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    KRW

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    77.97%
    20.38%
    Free Cash Flow
    - -
    4,907.03%
    50.44%
    Net Income, GAAP
    - -
    3,598.38%
    -8.59%
    Sales/Revenue/Turnover
    - -
    - -
    22.72%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    KRW

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    25,334
    30,770
    28,642
    31,803
    116,550
    2023
    29,105
    35,161
    39,107
    39,657
    143,030
    2024
    43,956
    45,104
    - -
    - -
    - -

    Quarterly Earnings Per Share

    KRW

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    92
    104
    101
    - -
    381
    2023
    92
    81.41
    104.05
    - -
    328
    2024
    91
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    KRW

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business